Jennifer A. Crozier

Folate Receptor-α (FOLR1) Expression and Function in Triple Negative Tumors

Brian M. Necela, Jennifer A. Crozier, Cathy Andorfer et al. · PLoS ONE · 2015 · 147 citations · Full text

Medicine, Molecular Biology, Oncology +17

Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis

Jennifer A. Crozier, Todd A. Pezzi, Caitlin Hodge et al. · The Lancet Oncology · 2020 · 75 citations

Medicine, Geriatric Medicine, Oncology +9

Effect of body mass index on tumor characteristics and disease‐free survival in patients from the HER2‐positive adjuvant trastuzumab trial N9831

Jennifer A. Crozier, Alvaro Moreno‐Aspitia, Karla V. Ballman et al. · Cancer · 2013 · 57 citations · Full text

Medicine, Biostatistics, Oncology +17

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

Jennifer A. Crozier, Pooja Advani, Betsy LaPlant et al. · Clinical Breast Cancer · 2015 · 56 citations

Medicine, Oncology, Pharmacology +16

Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review

Jennifer A. Crozier, Taimur Sher, Dongyun Yang et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 35 citations · Full text

Medicine, Immunology, Oncology +8